Related Experiment Video
Updated: Mar 7, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Novel mutation (Mangera-E288V) in alpha-1 antitrypsin deficiency
Giorgio Lorini1, Stefania Ottaviani2, Ilaria Giana1
1Unit of Respiratory Diseases, Department of Internal Medicine and Medical Therapeutics, University of Pavia Medical School, Pavia, Italy.
A novel SERPINA1 gene mutation, named Mangera, was identified in an Italian patient with severe alpha-1 antitrypsin deficiency (AATD). Despite deficiency, the patient showed minimal disease progression, underscoring the need for specialized diagnostics.
Area of Science:
- Genetics
- Pulmonology
- Hepatology
Background:
- Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder caused by SERPINA1 gene mutations.
- Various mutations are linked to lung and liver diseases.
- A novel mutation, Mangera, was discovered in an Italian patient.
Purpose of the Study:
- To report a novel SERPINA1 mutation, Mangera.
- To describe the clinical presentation and genetic findings in a patient with severe AATD.
- To emphasize the importance of specialized diagnostics for AATD.
Main Methods:
- Case report of a 64-year-old Italian male with severe AATD.
- Genetic analysis to identify SERPINA1 gene mutations.
- Pulmonary function tests and chest CT scans to assess disease severity.
Main Results:
- A novel mutation, Mangera, was identified in a patient with the S allele.
- The patient presented with mild airway obstruction and early emphysema.
- Despite severe AAT deficiency, clinical and radiological progression was minimal.
Conclusions:
- The Mangera mutation expands the known spectrum of SERPINA1 variants.
- Accurate diagnosis requires referral to specialized centers.
- Vigilance and thorough investigation are crucial for suspected AATD cases.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Mutations
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...

